Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001689375-23-000005
Filing Date
2023-01-30
Accepted
2023-01-30 16:32:53
Documents
1
Period of Report
2023-01-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_167511434830711.html 4  
1 FORM 4 wf-form4_167511434830711.xml 4 3810
  Complete submission text file 0001689375-23-000005.txt   5234
Mailing Address C/O AMICUS THERAPEUTICS 1 CEDAR BROOK DRIVE CRANBURY NJ 08512
Business Address
Doshi Dipal (Reporting) CIK: 0001613084 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40969 | Film No.: 23568279

Mailing Address 6 TIDE STREET BOSTON MA 02210
Business Address 6 TIDE STREET BOSTON MA 02210 857-305-1825
Entrada Therapeutics, Inc. (Issuer) CIK: 0001689375 (see all company filings)

EIN.: 813983399 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations